Lyell Immunopharma
(NASDAQ:LYEL)
$7.56
-0.09[-1.18%]
Last update: 3:35PM
Day High/Low7.44 - 7.91
52 Week High/Low3.57 - 7.82
Open / Close7.59 / -
Float / Outstanding172.3M / 247.8M
Vol / Avg.603K / 950.7K
Mkt Cap1.9B
P/E4.66
50d Avg. Price5.76
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float172.3M

Lyell Immunopharma (NASDAQ:LYEL), Quotes and News Summary

Lyell Immunopharma (NASDAQ: LYEL)

Day High/Low7.44 - 7.91
52 Week High/Low3.57 - 7.82
Open / Close7.59 / -
Float / Outstanding172.3M / 247.8M
Vol / Avg.603K / 950.7K
Mkt Cap1.9B
P/E4.66
50d Avg. Price5.76
Div / Yield-
Payout Ratio-
EPS-0.15
Total Float172.3M
Sector: Health Care.Industry: Biotechnology
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).

Earnings

see more
Q2 2022Est.ActualSurprise
EPS-0.040
REV35.741M
Q1 2022Est.ActualSurprise
EPS-0.200
REV553.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Lyell Immunopharma Questions & Answers

Q
How do I buy Lyell Immunopharma (LYEL) stock?
A

You can purchase shares of Lyell Immunopharma (NASDAQ: LYEL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Lyell Immunopharma's (LYEL) competitors?
Q
What is the target price for Lyell Immunopharma (LYEL) stock?
A

The latest price target for Lyell Immunopharma (NASDAQ: LYEL) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 12.00 expecting LYEL to rise to within 12 months (a possible 58.73% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Lyell Immunopharma (LYEL)?
A

The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $7.56 last updated Today at August 9, 2022, 7:35 PM UTC.

Q
Does Lyell Immunopharma (LYEL) pay a dividend?
A

There are no upcoming dividends for Lyell Immunopharma.

Q
When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?
A

Lyell Immunopharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Lyell Immunopharma (LYEL) going to split?
A

There is no upcoming split for Lyell Immunopharma.

Q
What sector and industry does Lyell Immunopharma (LYEL) operate in?
A

Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.